Mike Kleppinger

Managing Director, Innovative Business Unit at SEQENS

Mike Kleppinger, PhD, MBA is currently the President of Commercial Operations Clinical Research Group at Thermo Fisher Scientific. Prior to this role, Mike held executive positions in companies such as SEQENS, Curia, and Syneos Health, where Mike demonstrated exceptional leadership in business development, marketing, and sales. With an extensive background in various industries, Mike has a strong track record of success in driving revenue growth, developing strategic plans, and leading global teams to achieve business objectives. Their educational background includes a PhD in Business Management, Marketing, and Related Support Services, an MBA, and a Bachelor's degree in Business Administration.

Links

Timeline

  • Managing Director, Innovative Business Unit

    March, 2023 - present

A panel showing how The Org can help with contacting the right person.